Laddar...
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Outcomes for patients with glioblastoma (GBM) remain poor despite aggressive multimodal therapy. Immunotherapy with genetically modified T cells expressing chimeric antigen receptors (CARs) targeting interleukin (IL)-13Rα2, epidermal growth factor receptor variant III (EGFRvIII), or human epidermal...
Sparad:
| Huvudupphovsmän: | , , , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3589173/ https://ncbi.nlm.nih.gov/pubmed/23070117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.210 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|